Positron emission tomography: Contribution to diagnosis of dementia and development of disease modifying drugs

Japanese Journal of Neuropsychopharmacology

Volumn 29, Issue 4, 2009, Pages 153-160

  Ito, Kengo ^a   Kato, Takashi ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Alzheimer's disease; Amyloid imaging; Early diagnosis; Mild cognitive impairment; PET

Indexed keywords

AMYLOID; FLUORODEOXYGLUCOSE; NOOTROPIC AGENT;

ALZHEIMER DISEASE; CEREBROVASCULAR AMYLOID ANGIOPATHY; CEREBROVASCULAR DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; FRONTOTEMPORAL DEMENTIA; HUMAN; IMAGE ANALYSIS; MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER DISEASE; AMYLOID; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DRUG DISCOVERY; EARLY DIAGNOSIS; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; NIMODIPINE; NOOTROPIC AGENTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 70350070877     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Anchisi, D., Borroni, B., Franceschi, M., Kerrouche, N., Kalbe, E., Beuthien-Beumann, B., Cappa, S., Lenz, O., Ludecke, S., Marcone, A., Mielke, R., Ortelli, P., Padovani, A., Pelati, O., Pupi, A., Scarpini, E., Weisenbach, S., Herholz, K., Salmon, E., Holthoff, V., Sorbi, S., Fazio, F. and Perani, D. (2005) Heterogeneity of brain glucosemetabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol, 62: 1728-1733. (Pubitemid 41626670)
2. Burdette, J. H., Minoshima, S., Vander Borght, T., Tran, D. D., Kuhl, D. E. (1996) Alzheimer disease: Improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology, 198: 837-843. (Pubitemid 26066307)
3. Drzezga, A., Grimmer, T., Riemenschneider, M., Lautenschlager, N., Siebner, H., Alexopoulus, P., Minoshima, S., Schwaiger, M. and Kurz, A. (2005) Prediction of individual clinical outcome in MCI by means of genetic assessment and (18) F-FDG PET. J Nucl Med, 46: 1625-1632. (Pubitemid 46211586)
4. Edison, P., Rowe, C. C., Rinne, J. O., Ng, S., Ahmed, I., Kemppainen, N., Villemagne, V. L., O'Keefe, G., Någren, K., Chaudhury, K. R., Masters, C. L. and Brooks, D. J. (2008) Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry, Jul 24 [Epub].
5. Herholz, K., Salmon, E., Perani, D., Baron, J. C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., Kalbe, E., Zündorf, G., Delbeuck, X., Pelati, O., Anchisi, D., Fazio, F., Kerrouche, N., Desgranges, B., Eustache, F., Beuthien-Baumann, B., Menzel, C., Schröder, J., Kato, T., Arahata, Y., Henze, M. and Heiss, W. D. (2002) Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage, 17: 302-316.
6. Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., Debnath, M. L., Hope, C. E., Isanski, B. A., Hamilton, R. L. and DeKosky, S. T. (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain, 131: 1630-1645. (Pubitemid 351806448)
7. Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., Mathis, C. A., Price, J. C., Dekosky, S. T., Fischman, A. J. and Greenberg, S. M. (2007) Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol, 62: 229-234. (Pubitemid 47525398)
8. Klunk, W. E., Wang, Y., Huang, G. F., Debnath, M. L., Holt, D. P. and Mathis, C. A. (2001) Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci, 69: 1471-1484 (Pubitemid 32786721)
9. Kudo, Y., Okamura, N., Furumoto, S., Tashiro, M., Furukawa, K., Maruyama, M., Itoh, M., Iwata, R., Yanai, K. and Arai, H. (2007) 2-(2-[2- Dimethylaminothiazol-5-yl] ethenyl)-6-(2-[fluoro] ethoxy) benzoxazole: A novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J Nucl Med, 48: 553-561.
10. Leinonen, V., Alafuzoff, I., Aalto, S., Suotunen, T., Savolainen, S., Någren, K., Tapiola, T., Pirttilä, T., Rinne, J., Jääskeläinen, J. E., Soininen, H. and Rinne, J. O. (2008) Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol, Aug 11 [Epub].
11. Maetzler, W., Reimold, M., Liepelt, I., Solbach, C., Leyhe, T., Schweitzer, K., Eschweiler, G. W., Mittelbronn, M., Gaenslen, A., Uebele, M., Reischl, G., Gasser, T., Machulla, H. J., Bares, R. and Berg, D. (2008) [11C]PIB binding in Parkinson's disease dementia. Neuroimage, 39: 1027-1033.
12. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol, 56: 303-308.
13. Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thai, L. and Winblad, B. (2001) Current concepts in mild cognitive impairment. Arch Neurol, 58: 1985-1992. (Pubitemid 33143977)
14. Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C.L. and Rowe, C. C. (2007) Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease. Brain, 130: 2837-2844. (Pubitemid 350033975)
15. Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., Smith, C., Woodward, M., Merory, J., Tochon-Danguy, H., O'Keefe, G., Klunk, W. E., Mathis, C. A., Price, J. C., Masters, C. L. and Villemagne, V. L. (2007) Imaging beta-amyloid burden in aging and dementia. Neurology, 68: 1718-1725. (Pubitemid 46763260)
16. Silverman, D. H. (2004) Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: Comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med, 45: 594-607.
17. Winblad, B,. Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. O., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., Arai, H., Basun, H., Blennow, K., de Leon, M., DeCarli, C., Erkinjuntti, T., Giacobini, E., Graff, C., Hardy, J., Jack, C., Jorm, A., Ritchie, K., van Duijn, C., Visser, P. and Petersen, R. C. (2004) Mild cognitive impairment - beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med, 256: 240-246. (Pubitemid 39222993)